vs
NATURES SUNSHINE PRODUCTS INC（NATR）とRibbon Communications Inc.（RBBN）の財務データ比較。上の社名をクリックして会社を切り替えられます
Ribbon Communications Inc.の直近四半期売上が大きい（$162.6M vs $123.8M、NATURES SUNSHINE PRODUCTS INCの約1.3倍）。Ribbon Communications Inc.の純利益率が高く（54.8% vs 3.3%、差は51.5%）。NATURES SUNSHINE PRODUCTS INCの前年同期比売上増加率が高い（4.7% vs -10.3%）。過去8四半期でNATURES SUNSHINE PRODUCTS INCの売上複合成長率が高い（5.6% vs -8.1%）
Natures Sunshine Products, Inc.（通称NSP）は、ハーブ、ビタミン、ミネラルを含む栄養補助食品やスキンケアなどのパーソナルケア製品の製造を行っています。本社はユタ州リーハイに置き、同州スパニッシュフォークに生産拠点を構えています。
Ribbon Communications Inc.は通信事業者、企業、重要インフラ分野に向け、ソフトウェア、IPおよび光ネットワークソリューションを提供する企業です。2017年にGenbandとSonus Networksが合併して設立され、本社は米国テキサス州プレイノに置かれている上場企業です。
NATR vs RBBN — 直接比較
損益計算書 — Q4 FY2025 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $123.8M | $162.6M |
| 純利益 | $4.1M | $89.1M |
| 粗利率 | 72.5% | 42.9% |
| 営業利益率 | 4.3% | 37.6% |
| 純利益率 | 3.3% | 54.8% |
| 売上前年比 | 4.7% | -10.3% |
| 純利益前年比 | 1379.4% | — |
| EPS（希薄化後） | $0.23 | $0.50 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | — | $162.6M | ||
| Q4 25 | $123.8M | $227.3M | ||
| Q3 25 | $128.3M | $215.4M | ||
| Q2 25 | $114.8M | $220.6M | ||
| Q1 25 | $113.2M | $181.3M | ||
| Q4 24 | $118.2M | $251.4M | ||
| Q3 24 | $114.6M | $210.2M | ||
| Q2 24 | $110.6M | $192.6M |
| Q1 26 | — | $89.1M | ||
| Q4 25 | $4.1M | — | ||
| Q3 25 | $5.3M | $-12.1M | ||
| Q2 25 | $5.3M | $-11.1M | ||
| Q1 25 | $4.7M | $-26.2M | ||
| Q4 24 | $-321.0K | — | ||
| Q3 24 | $4.3M | $-13.4M | ||
| Q2 24 | $1.3M | $-16.8M |
| Q1 26 | — | 42.9% | ||
| Q4 25 | 72.5% | 53.3% | ||
| Q3 25 | 73.3% | 50.1% | ||
| Q2 25 | 71.7% | 49.6% | ||
| Q1 25 | 72.1% | 45.4% | ||
| Q4 24 | 72.0% | 55.7% | ||
| Q3 24 | 71.3% | 52.1% | ||
| Q2 24 | 71.4% | 50.8% |
| Q1 26 | — | 37.6% | ||
| Q4 25 | 4.3% | 4.1% | ||
| Q3 25 | 7.0% | 1.3% | ||
| Q2 25 | 3.7% | 1.9% | ||
| Q1 25 | 5.4% | -10.8% | ||
| Q4 24 | 3.8% | 13.2% | ||
| Q3 24 | 4.6% | -0.4% | ||
| Q2 24 | 5.1% | -1.0% |
| Q1 26 | — | 54.8% | ||
| Q4 25 | 3.3% | — | ||
| Q3 25 | 4.2% | -5.6% | ||
| Q2 25 | 4.6% | -5.0% | ||
| Q1 25 | 4.2% | -14.5% | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | 3.8% | -6.4% | ||
| Q2 24 | 1.2% | -8.7% |
| Q1 26 | — | $0.50 | ||
| Q4 25 | $0.23 | $0.50 | ||
| Q3 25 | $0.30 | $-0.07 | ||
| Q2 25 | $0.28 | $-0.06 | ||
| Q1 25 | $0.25 | $-0.15 | ||
| Q4 24 | $-0.02 | $0.05 | ||
| Q3 24 | $0.23 | $-0.08 | ||
| Q2 24 | $0.07 | $-0.10 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $93.9M | $67.6M |
| 総負債低いほど良い | — | — |
| 株主資本純資産 | $161.6M | $419.1M |
| 総資産 | $261.1M | — |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | — | $67.6M | ||
| Q4 25 | $93.9M | $96.4M | ||
| Q3 25 | $95.6M | $74.8M | ||
| Q2 25 | $81.3M | $60.5M | ||
| Q1 25 | $86.5M | $71.2M | ||
| Q4 24 | $84.7M | $87.8M | ||
| Q3 24 | $78.7M | $37.2M | ||
| Q2 24 | $68.7M | $64.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $342.1M | ||
| Q3 25 | — | $344.3M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $347.4M | ||
| Q4 24 | — | $348.3M | ||
| Q3 24 | — | $349.1M | ||
| Q2 24 | — | $350.0M |
| Q1 26 | — | $419.1M | ||
| Q4 25 | $161.6M | $449.0M | ||
| Q3 25 | $166.7M | $360.1M | ||
| Q2 25 | $163.7M | $370.4M | ||
| Q1 25 | $167.1M | $381.8M | ||
| Q4 24 | $161.0M | $404.6M | ||
| Q3 24 | $162.6M | $395.5M | ||
| Q2 24 | $156.4M | $405.0M |
| Q1 26 | — | — | ||
| Q4 25 | $261.1M | $1.2B | ||
| Q3 25 | $264.8M | $1.1B | ||
| Q2 25 | $254.9M | $1.1B | ||
| Q1 25 | $252.7M | $1.1B | ||
| Q4 24 | $240.9M | $1.2B | ||
| Q3 24 | $245.3M | $1.1B | ||
| Q2 24 | $235.8M | $1.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.96× | ||
| Q2 25 | — | 0.94× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | 0.86× | ||
| Q3 24 | — | 0.88× | ||
| Q2 24 | — | 0.86× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $9.9M | — |
| フリーキャッシュフロー営業CF - 設備投資 | $7.6M | — |
| FCFマージンFCF / 売上 | 6.1% | — |
| 設備投資強度設備投資 / 売上 | 1.9% | — |
| キャッシュ転換率営業CF / 純利益 | 2.41× | — |
| 直近12ヶ月FCF直近4四半期 | $28.8M | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | — | — | ||
| Q4 25 | $9.9M | $29.2M | ||
| Q3 25 | $18.5M | $26.5M | ||
| Q2 25 | $4.3M | $-795.0K | ||
| Q1 25 | $2.6M | $-3.5M | ||
| Q4 24 | $12.2M | $61.8M | ||
| Q3 24 | $9.6M | $-14.8M | ||
| Q2 24 | $1.3M | $-9.8M |
| Q1 26 | — | — | ||
| Q4 25 | $7.6M | $27.3M | ||
| Q3 25 | $16.8M | $21.0M | ||
| Q2 25 | $3.0M | $-6.5M | ||
| Q1 25 | $1.5M | $-15.7M | ||
| Q4 24 | $10.0M | $53.8M | ||
| Q3 24 | $7.9M | $-23.7M | ||
| Q2 24 | $-2.0M | $-12.9M |
| Q1 26 | — | — | ||
| Q4 25 | 6.1% | 12.0% | ||
| Q3 25 | 13.1% | 9.7% | ||
| Q2 25 | 2.6% | -2.9% | ||
| Q1 25 | 1.3% | -8.7% | ||
| Q4 24 | 8.5% | 21.4% | ||
| Q3 24 | 6.9% | -11.3% | ||
| Q2 24 | -1.9% | -6.7% |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 0.9% | ||
| Q3 25 | 1.3% | 2.6% | ||
| Q2 25 | 1.2% | 2.6% | ||
| Q1 25 | 1.0% | 6.7% | ||
| Q4 24 | 1.9% | 3.2% | ||
| Q3 24 | 1.5% | 4.2% | ||
| Q2 24 | 3.0% | 1.6% |
| Q1 26 | — | — | ||
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
RBBN
| Service | $94.5M | 58% |
| Product | $68.1M | 42% |
